Adaptimmune Therapeutics shares owned by Quadrant Capital
Quarter-by-quarter ownership of Adaptimmune Therapeutics (ADAP) shares owned by Quadrant Capital
from 13F filings
Historical chart of Quadrant Capital investment in Adaptimmune Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Adaptimmune Therapeutics held by Quadrant Capital consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Adaptimmune Therapeutics by Quadrant Capital
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-09-30 | $12k | 12k | 0.95 |
2024-06-30 | $3.1k | 3.2k | 0.98 |
2024-03-31 | $9.9k | 6.3k | 1.58 |
2022-09-30 | $999 | 1.0k | 0.96 |
2021-12-31 | $9.0k | 2.5k | 3.65 |
2021-09-30 | $17k | 3.2k | 5.28 |
2020-06-30 | $1.0k | 131 | 7.63 |